BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2022 Earnings Call Transcript March 16, 2023 Operator: Good day, and welcome to the BioLife Solutions’ Fourth Quarter 2022 and Full Year Earnings Call. Today’s call is being recorded. I would now like to turn the conference over to Troy Wichterman, Chief Financial Officer. Please go ahead. Troy Wichterman: Thank […]
Q4 2022 BioLife Solutions Inc Earnings Call
BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (CGT) and the broader biopharma markets, today announced financial results for the fourth quarter and year ended December 31, 2022.